Alper B. İskit

1.3k total citations
67 papers, 1.0k citations indexed

About

Alper B. İskit is a scholar working on Physiology, Pathology and Forensic Medicine and Biochemistry. According to data from OpenAlex, Alper B. İskit has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 13 papers in Pathology and Forensic Medicine and 12 papers in Biochemistry. Recurrent topics in Alper B. İskit's work include Nitric Oxide and Endothelin Effects (20 papers), Eicosanoids and Hypertension Pharmacology (12 papers) and Cardiac Ischemia and Reperfusion (12 papers). Alper B. İskit is often cited by papers focused on Nitric Oxide and Endothelin Effects (20 papers), Eicosanoids and Hypertension Pharmacology (12 papers) and Cardiac Ischemia and Reperfusion (12 papers). Alper B. İskit collaborates with scholars based in Türkiye, United Kingdom and Japan. Alper B. İskit's co-authors include M. Oguz Güc, Sevda Şenel, Erem Bilensoy, Pelin Aksungur, Arzu Sungur, Christopher A. Squier, Serhat Ünal, Nazlı Erdoğar, Mustafa İlhan and Hülagu Barışkaner and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and European Urology.

In The Last Decade

Alper B. İskit

65 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alper B. İskit Türkiye 21 206 180 135 133 126 67 1.0k
Maher A. Kamel Egypt 24 318 1.5× 204 1.1× 72 0.5× 68 0.5× 94 0.7× 104 1.5k
Miwon Son South Korea 26 448 2.2× 184 1.0× 199 1.5× 175 1.3× 60 0.5× 78 1.7k
Hussain Ali Pakistan 24 440 2.1× 180 1.0× 89 0.7× 378 2.8× 156 1.2× 43 1.7k
Mohammed Gulrez Zariwala United Kingdom 20 286 1.4× 159 0.9× 50 0.4× 112 0.8× 48 0.4× 48 938
Laurie B. Joseph United States 19 448 2.2× 238 1.3× 79 0.6× 51 0.4× 136 1.1× 53 1.1k
Jin‐Ju Kim South Korea 19 408 2.0× 117 0.7× 135 1.0× 54 0.4× 120 1.0× 62 1.4k
Jamal Hallajzadeh Iran 22 402 2.0× 136 0.8× 67 0.5× 60 0.5× 46 0.4× 63 1.2k
Tse‐Hung Huang Taiwan 23 761 3.7× 133 0.7× 115 0.9× 157 1.2× 299 2.4× 83 2.2k
Pejman Mortazavi Iran 20 254 1.2× 144 0.8× 109 0.8× 42 0.3× 39 0.3× 108 1.1k

Countries citing papers authored by Alper B. İskit

Since Specialization
Citations

This map shows the geographic impact of Alper B. İskit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alper B. İskit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alper B. İskit more than expected).

Fields of papers citing papers by Alper B. İskit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alper B. İskit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alper B. İskit. The network helps show where Alper B. İskit may publish in the future.

Co-authorship network of co-authors of Alper B. İskit

This figure shows the co-authorship network connecting the top 25 collaborators of Alper B. İskit. A scholar is included among the top collaborators of Alper B. İskit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alper B. İskit. Alper B. İskit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
İskit, Alper B.. (2025). Biosimilars and interchangeability: Regulatory, scientific, and global perspectives. European Journal of Pharmaceutical Sciences. 213. 107224–107224.
2.
Sara, Yıldırım, et al.. (2024). In vitro effects of β3‐adrenoceptor agonist mirabegron on the human ureter. Neurourology and Urodynamics. 43(7). 1709–1717. 1 indexed citations
3.
4.
Gündüz, Miyase Gözde, et al.. (2017). Synthesis of fused 1,4-dihydropyridines as potential calcium channel blockers. Turkish Journal of Biochemistry. 43(6). 578–586. 15 indexed citations
5.
Baxter, Gary F., et al.. (2017). Cardioprotective effects of Viscum album L. subsp. album (European misletoe) leaf extracts in myocardial ischemia and reperfusion. Journal of Ethnopharmacology. 209. 203–209. 19 indexed citations
6.
Kılınç, İbrahim, et al.. (2016). Celecoxib administration reduced mortality, mesenteric hypoperfusion, aortic dysfunction and multiple organ injury in septic rats. Biomedicine & Pharmacotherapy. 86. 583–589. 21 indexed citations
7.
Çil, Onur, Mert Ertunç, Şafak Güçer, et al.. (2012). Endothelial Dysfunction and Increased Responses to Renal Nerve Stimulation in Rat Kidneys during Rhabdomyolysis-Induced Acute Renal Failure: Role of Hydroxyl Radical. Renal Failure. 34(2). 211–220. 8 indexed citations
8.
Harput, Ü. Şebnem, Okan Arıhan, Alper B. İskit, Akito Nagatsu, & İclal Saraçoğlu. (2011). Antinociceptive, Free Radical–Scavenging, and Cytotoxic Activities of Acanthus hirsutus Boiss. Journal of Medicinal Food. 14(7-8). 767–774. 27 indexed citations
9.
Altıntaş, Neriman Defne, Pergin Atilla, Alper B. İskit, & Arzu Topeli̇. (2011). Long-Term Simvastatin Attenuates Lung Injury and Oxidative Stress in Murine Acute Lung Injury Models Induced by Oleic Acid and Endotoxin. Respiratory Care. 56(8). 1156–1163. 22 indexed citations
10.
Avşar, Fatih Mehmet, et al.. (2009). The Effects of <i>L</i>-N<sup>G</sup>-Nitroarginine in a Zymosan-Induced Multiple Organ Dysfunction Syndrome Model. European Surgical Research. 43(2). 211–218.
11.
İskit, Alper B., et al.. (2006). Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving KATP channels. Vascular Pharmacology. 46(2). 129–136. 5 indexed citations
12.
İskit, Alper B., et al.. (2006). The effect of nitric oxide on fentanyl and haloperidol-induced catalepsy in mice *. European Journal of Anaesthesiology. 23(7). 580–585. 4 indexed citations
13.
Dal, D., et al.. (2005). The effect of ketamine on acute muscular ischaemia reperfusion in rats. European Journal of Anaesthesiology. 22(9). 712–716. 15 indexed citations
14.
Raşa, Kemal, et al.. (2004). The effects of selective nitric oxide synthase blocker on survival, mesenteric blood flow and multiple organ failure induced by zymosan1. Journal of Surgical Research. 124(1). 67–73. 11 indexed citations
15.
İskit, Alper B., et al.. (2004). Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock. European Journal of Pharmacology. 506(1). 83–88. 26 indexed citations
16.
Aksungur, Pelin, Arzu Sungur, Serhat Ünal, et al.. (2004). Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. Journal of Controlled Release. 98(2). 269–279. 136 indexed citations
17.
İskit, Alper B., et al.. (1999). EFFECTS OF ADRENALINE OR ENDOTOXIN TOLERANCE STATES ON MESENTERIC BLOOD FLOW IN ENDOTOXAEMIA. Australian and New Zealand Journal of Surgery. 69(2). 134–137. 10 indexed citations
18.
İskit, Alper B., et al.. (1999). The effects of bosentan, aminoguanidine and l-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice. European Journal of Pharmacology. 379(1). 73–80. 37 indexed citations
19.
Salman, Ahmet Bedii, et al.. (1998). Hemodynamic Monitoring of the Contralateral Testis during Unilateral Testicular Torsion Describes the Mechanism of Damage. European Urology. 33(6). 576–580. 20 indexed citations
20.
İskit, Alper B., M. Oguz Güc, & Mustafa İlhan. (1997). l-Canavanine and dexamethasone attenuate endotoxin-induced suppression of ischaemia-reperfusion arrhythmias. European Journal of Pharmacology. 326(2-3). 183–190. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026